A diagnosis needs context
Growth hormone is a substance that sends signals inside the body. A shortage of it is a medical condition with approved treatments, as described in the FDA review checked on October 1, 2026.
Assessment usually combines signs and symptoms with at least two special blood tests. Each test uses a different substance to make the body release growth hormone, then measures the response.
The tests needed can vary with a person’s illnesses and other hormone shortages.
A single reading has limits
Growth hormone levels change through the day, so a single random reading cannot diagnose a shortage.
IGF-1 is another substance measured in the blood during a growth hormone check. Its level cannot establish a growth hormone shortage on its own either.
Ask what a proposed test is meant to answer and how its result could change your care.
Ask about care for the actual condition
The FDA review says ipamorelin cannot prompt growth hormone release when the body makes none.
If a shortage is suspected, ask who will confirm it and discuss treatment options for that diagnosis.
If the concern is sleep, energy or body changes, describe that concern first rather than starting with a requested drug.